Yasir Taha, MD
Interventional Cardiology · Atlanta, GANPI 1083928279
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (52.5%), travel and lodging and education — rather than concentrated in one kind of arrangement. 17 manufacturers reported payments, led by Edwards Lifesciences at 43.7% of the total. Reporting peaked in 2021 at $1,675 and has fallen 86.4% since, to $228 in 2025. That places this record below the midpoint for interventional cardiology clinicians in GA, where the typical reported total is $7,640.
Across 44 payments — averaging $60.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Edwards Lifesciences$1K
- Boston Scientific$502
- Bard Peripheral Vascular, Inc.$291
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$119
- Stryker$116
- Cardiovascular Systems Inc.$99
- plus $376 from 11 others
Across 3 payments — averaging $20,757 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novartis$62K
What the payments were for
- Travel & lodging$68926%
- Food & beverage$1,40153%
- Education$57822%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Edwards Lifesciences | 10 | $1,165 |
| Boston Scientific | 6 | $502 |
| Bard Peripheral Vascular, Inc. | 2 | $291 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 7 | $119 |
| Stryker | 2 | $116 |
| Cardiovascular Systems Inc. | 5 | $99 |
| Angiodynamics, Inc. | 2 | $87 |
| Siemens Medical Solutions USA, Inc. | 1 | $76 |
| Inari Medical, Inc. | 1 | $32 |
| Nuwellis, Inc. | 1 | $30 |
| Abbott | 1 | $27 |
| Novartis | 1 | $25 |
| Merck | 1 | $23 |
| Philips North America LLC | 1 | $22 |
| Actelion Pharmaceuticals US, Inc. | 1 | $22 |
| Medtronic | 1 | $18 |
| Pfizer | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Watchman$125
- GENERAL VASCULAR ACCESS$114
How this compares
$2,668 in reported general payments places this provider in the 15th percentile of 218 interventional cardiology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| FarxigaDapagliflozin Propanediol | 14 | $18,734 |
| Metoprolol Succinate | 17 | $359 |
| Rosuvastatin Calcium | 13 | $141 |
| Carvedilol | 11 | $86 |
| Spironolactone | 15 | $77 |
| Furosemide | 18 | $47 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Atlanta
- William NicholsonAtlanta$1000K
- David KandzariAtlanta$982K
- Pradeep YadavAtlanta$656K
- Adam GreenbaumAtlanta$238K
- Wissam JaberAtlanta$222K
- Katherine KunkelAtlanta$189K
- James StewartAtlanta$174K
- Pratik SandesaraAtlanta$165K
- Chandanreddy DevireddyAtlanta$121K
- Prashant KaulAtlanta$109K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.